Showing posts with label Teva. Show all posts
Showing posts with label Teva. Show all posts

Tuesday, February 7, 2012

Gap (GPS) (UL) (WHR) (TEVA) (TOL) (HITT) (ABMD) Ratings, Price Targets

The Gap Inc. (NYSE: GPS), Unilever (NYSE: UL), Whirlpool (NYSE: WHR), Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA), Toll Brothers, Inc. (NYSE: TOL), Hittite Microwave (NASDAQ: HITT) and Abiomed (NASDAQ: ABMD) had ratings and price targets on them adjusted by analysts.

Unilever (UL) was upgraded by Goldman Sachs (NYSE:GS) to a “Conviction Buy” rating.

Whirlpool (WHR) was upgraded by Longbow Research from a “Neutral” rating to a “Buy” rating. They have a price target of $81.00 on the company.

Teva Pharmaceutical Industries Ltd (TEVA) was downgraded by Morgan Stanley (NYSE:MS) from an “Overweight” rating to an “Equal Weight” rating.

Toll Brothers, Inc. (TOL) was downgraded by Raymond James (NYSE:RJF) from an “Outperform” rating to a “Market Perform” rating.

The Gap Inc. (GPS) was downgraded by Standpoint Research from a “Buy” rating to a “Hold” rating.

Hittite Microwave (HITT) was downgraded by Needham & Company from a “Buy” rating to a “Hold” rating.

Abiomed (ABMD) had its price target raised by Piper Jaffray (NYSE:PJC) to $25.00.